A systematic review of the cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer

被引:0
|
作者
Frank, M. [1 ]
Lange, A. [1 ]
Prenzler, A. [1 ]
Kirstein, M. [2 ]
Vogel, A. [2 ]
von der Schulenburg, Graf J. -M [1 ]
机构
[1] CHERH, Hannover, Germany
[2] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, D-30623 Hannover, Germany
来源
ONKOLOGIE | 2013年 / 36卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [31] Cost-effectiveness of risk-tailored screening strategy for colorectal cancer: A systematic review
    Wang, Le
    Liu, Chengcheng
    Wang, Youqing
    Du, Lingbin
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (07) : 1235 - 1243
  • [32] Cost-effectiveness of RAS testing in colorectal cancer. A systematic review of economic evaluations
    Unim, B.
    Pitini, E.
    D'Andrea, E.
    De Vito, C.
    Marzuillo, C.
    Villari, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 93 - 93
  • [33] Cost of treating metastatic colorectal cancer: a systematic review
    Bhimani, N.
    Wong, G. Y. M.
    Molloy, C.
    Pavlakis, N.
    Diakos, C. I.
    Clarke, S. J.
    Dieng, M.
    Hugh, T. J.
    PUBLIC HEALTH, 2022, 211 : 97 - 104
  • [34] BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: A LITERATURE REVIEW ON META-ANALYSES AND COST-EFFECTIVENESS ANALYSES
    Sun, Y.
    Liu, G.
    VALUE IN HEALTH, 2014, 17 (07) : A733 - A733
  • [35] COST-EFFECTIVENESS OF TRIFLURIDINE/TIPIRACIL FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN PORTUGAL
    Almeida, J.
    Vandewalle, B.
    Felix, J.
    Amorim, A.
    Henriques, J.
    Wang-Silvanto, J.
    Haffemayer, B.
    Branscombe, N.
    VALUE IN HEALTH, 2017, 20 (09) : A437 - A437
  • [36] Cost-effectiveness for extended RAS/RAF testing in metastatic colorectal cancer
    Al-Hajeili, Marwan R.
    Elkhider, Faris
    Tiba, M. Hakam
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Drug cost and outcome in metastatic colorectal cancer with emphasis on monoclonal antibodies.
    Guirgis, Helmy M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [38] Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies
    Mauri, Gianluca
    Pizzutilo, Elio Gregory
    Amatu, Alessio
    Bencardino, Katia
    Palmeri, Laura
    Bonazzina, Erica Francesca
    Tosi, Federica
    Stella, Giulia Carlo
    Burrafato, Giovanni
    Scaglione, Francesco
    Marsoni, Silvia
    Siravegna, Giulia
    Bardelli, Alberto
    Siena, Salvatore
    Sartore-Bianchi, Andrea
    CANCER TREATMENT REVIEWS, 2019, 73 : 41 - 53
  • [39] COST-EFFECTIVENESS OF SORAFENIB FOR METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW
    Taheri, S.
    Motevalli, M. H.
    Peiravian, F.
    Yousefi, N.
    VALUE IN HEALTH, 2018, 21 : S42 - S42
  • [40] Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models
    Diedrich, Leonie
    Brinkmann, Melanie
    Dreier, Maren
    Rossol, Siegbert
    Schramm, Wendelin
    Krauth, Christian
    PLOS ONE, 2023, 18 (08):